EUVIMEDEUVIMED entdecken
Crossref

Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health

Chieh Chen, Da-Ming Liao

Aging Pathobiology and Therapeutics · 25.09.2026 · 8 (3)

DOI: 10.31491/apt.2026.09.238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Pathobiology and Therapeutics, online erschienen am 30.09.2026. Verfasst von Chieh Chen und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chen, C., & Liao, D. (2026). Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health. Aging Pathobiology and Therapeutics, 8(3). https://doi.org/10.31491/apt.2026.09.238

Vancouver

Chen C, Liao D. Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health. Aging Pathobiology and Therapeutics. 2026;8(3). doi:10.31491/apt.2026.09.238

BibTeX
@article{Chen2026,
  author = {Chen, Chieh and Liao, Da-Ming},
  title = {Rethinking sarcopenia screening in middle age—The 2025 AWGS consensus and its implications for cognitive health},
  journal = {Aging Pathobiology and Therapeutics},
  year = {2026},
  volume = {8},
  number = {3},
  doi = {10.31491/apt.2026.09.238}
}
Kostenlos starten →